Erlonat 150mg Tablet

About

Erlonat 150 mg Tablet is an anticancer medicine used to treat advanced or metastatic non-small cell lung cancer. It is also prescribed in combination with gemcitabine for the treatment of metastatic pancreatic cancer. Cancer occurs when cells grow and multiply abnormally and uncontrollably in the body.

Treatment with Erlonat 150 mg Tablet may affect kidney and liver function, so your doctor will regularly monitor these parameters. Inform your physician if you have any clotting disorders or are taking medicines that affect blood clotting, as this medicine can increase the risk of bleeding.

Seek medical advice promptly if you experience eye pain, blurred vision, cough, fever, shortness of breath, severe abdominal pain, or persistent diarrhea during treatment. Avoid smoking while on this medication, as it can lower the amount of the drug in your bloodstream. When outdoors, wear protective clothing and use sunscreen to protect your skin.

Serious:

• Liver failure
• Pain in the eye, blurred vision
• Persistent or severe diarrhea
• Severe pain in your abdomen
• Sudden difficulty in breathing accompanied by cough and fever

Common:

• Rash, worsened in sun-exposed areas
• Acne, cracked skin
• Hair loss, dry skin, itching
• Loss of appetite, decreased weight
• Depression
• Infection
• Bleeding from nose, stomach, intestines
• Indigestion, stomach pain, buildup of gas
• Mouth irritation
• Nausea
• Headache, changes in skin sensation
• Inflammation around fingernail
• Abnormal liver function
• Tiredness, fever
• Reduced kidney function
  
  

Safety Measures

Alcohol - It is not known whether consuming alcohol with Erlonat 150 mg Tablet is safe. Please consult your doctor for guidance.
Pregnancy - Erlonat 150 mg Tablet can harm an unborn baby. Do not take this medicine during pregnancy unless your doctor specifically recommends it. Inform your doctor if you are pregnant, suspect you may be pregnant, or are planning to become pregnant before starting this treatment.
BreastFeeding - Do not take Erlonat 150 mg Tablet while breastfeeding, as it may harm your baby. Consult your doctor to understand the potential risks and benefits before starting this medicine.
Liver - This medicine should be avoided in patients with severe liver disease. Inform your doctor if you have any liver problems.
Kidney - Erlonat 150 Tablet is generally safe for patients with mild to moderate kidney disease, and no dose adjustment is usually required. However, its use is not recommended in patients with severe kidney disease.


Disclaimer

Med E Hub is committed to delivering reliable, expert-reviewed information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.